Oral Oncology Therapies and Medicare Drug Coverage
Medicare coverage of oral oncology therapies has expanded significantly over the last five years with the advent of the Part D prescription drug benefit. Why does expanded coverage not always translate to expanded access for Medicare patients? Brenda Morrow, Vice President Emeritus, Payer Policy with AccessMED, a service of McKesson Specialty Health, discussed the Medicare Part D benefit and ways to help your patients gain access to oral therapies.

• What is the difference in patient cost-share when an oral drug is covered by Part B vs. Part D?
• What options are available for patients who can't afford the Part D cost-share?
• What does this mean for you and your patients?